Back |
home / stock / mrtx / mrtx message board
Subject | By | Source | When |
---|---|---|---|
I'm in !!!!! Glta | omri | investorshub | 09/15/2017 2:50:07 PM |
Looking good.. | Tdash | investorshub | 09/15/2017 2:38:51 PM |
preliminary on going phase II results.... much more | crudeoil24 | investorshub | 09/15/2017 12:50:30 PM |
Exactly! Do not hold over night for most | crudeoil24 | investorshub | 09/15/2017 12:45:08 PM |
Easy new comers don't get caught bag holding. | jones99 | investorshub | 09/15/2017 9:12:33 AM |
Yes no DD except the technicals were signaling | swampboots | investorshub | 09/23/2016 10:46:12 PM |
Yeah but didn't catch the high or near | girlfriend | investorshub | 09/23/2016 10:09:41 PM |
Nice out! | swampboots | investorshub | 09/23/2016 9:50:32 PM |
$MRTX looking good this morn out some at | girlfriend | investorshub | 09/22/2016 3:25:21 PM |
I will take a look thanks. | girlfriend | investorshub | 09/21/2016 7:21:24 PM |
You too! | Klinsmann | investorshub | 09/21/2016 7:10:05 PM |
I hear you.looks like $MRTX continuing here. | girlfriend | investorshub | 09/21/2016 6:58:44 PM |
News, Short Squeeze, Breakout and More Instantly...
Mirati Therapeutics Inc. Company Name:
MRTX Stock Symbol:
NASDAQ Market:
Mirati Therapeutics Inc. Website:
First Solar Inc. (FSLR) is expected to report $3.19 for Q4 2023 VIZIO Holding Corp. Class A (VZIO) is expected to report $0.02 for Q4 2023 Henry Schein Inc. (HSIC) is expected to report $0.71 for Q4 2023 Republic Services Inc. (RSG) is expected to report $1.28 for Q4 2023 Forge Gl...
European Commission Approves KRAZATI (adagrasib) as a Targeted Treatment Option for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation PR Newswire SAN DIEGO and ZUG, Switzerland , Jan. 10, 2024 /PRNewswire/ -- Mirati The...
2023-12-18 23:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...